Harbor Advisors’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,400
Closed -$126K 179
2023
Q3
$126K Hold
12,400
0.03% 154
2023
Q2
$161K Hold
12,400
0.03% 140
2023
Q1
$115K Hold
12,400
0.03% 138
2022
Q4
$135K Hold
12,400
0.03% 143
2022
Q3
$50K Hold
12,400
0.01% 158
2022
Q2
$90K Hold
12,400
0.02% 163
2022
Q1
$112K Hold
12,400
0.02% 160
2021
Q4
$139K Buy
+12,400
New +$155K 0.03% 165

Other funds holding PROF

Harbor Advisors's PROF Position: Q4 2023 in Review

Harbor Advisors sold out of Profound Medical (PROF) in Q4 2023, closing a stake of 12,400 shares — an estimated $126K sold.

Harbor Advisors first reported a position in PROF in Q4 2021 and held it in 8 quarters. The position peaked at $161K in Q2 2023. 45 funds tracked by Wall St. Rank hold PROF as of Q4 2023.

  • Harbor Advisors reported no remaining Profound Medical position as of Q4 2023 after selling out during the quarter.
  • Harbor Advisors sold 12,400 Profound Medical shares in Q4 2023, an estimated $126K.
  • Harbor Advisors first reported a position in Profound Medical in Q4 2021 and held it in 8 quarters.
  • Harbor Advisors's Profound Medical position peaked at $161K in Q2 2023.
  • 45 funds tracked by Wall St. Rank held Profound Medical as of Q4 2023.

Based on Harbor Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.